Monday, October 12, 2015 9:18:38 AM
LAS VEGAS, Oct. 12, 2015 (GLOBE NEWSWIRE) -- (OTCQB:VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabis-based prescription medicines to meet patients' needs for a wide range of medical conditions, is pleased to announce it will be sponsoring and presenting at the twenty-third annual Huntington Study Group Conference (http://huntingtonstudygroup.org/) This year's conference, HSG 2015: Building Our Future is being held from October 21-24, 2015 at the Grand Hyatt, Tampa Bay, FL.
Read more: http://www.nasdaq.com/press-release/verde-science-to-sponsorpresent-at-the-huntington-study-group-annual-conference-20151012-00395#ixzz3oMLKdTH1
Everything I post is my opinion and for entertainment purposes
only! Text ottorocks to 84483 for text alerts!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM